Atea Pharmaceuticals Inc (AVIR)

Net Income Growth

-21.42%

TTM · Period ending:

AVIR logo

AVIR Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-21.42%
AVIR TTM Net Income YoY % (22.00% → -21.42%)
High-resolution chart · PNG

AVIR net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Atea Pharmaceuticals Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-21.4226%
-21.528%
5.9602%
15.5058%
22.6538%
14.7686%
-23.8526%
-32.6033%
-65.805%
-49.7342%
-17.2955%
-468.0457%
-783.6725%
-325.8244%
-195.6424%
44.2664%
-55.9995%
103.7552%
1,207.0613%
168.1615%
258.4606%
250.0663%
21.9966%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.